3 studies found for:    Hypericin
Show Display Options
Rank Status Study
1 Not yet recruiting Topical SGX301 (Synthetic Hypericin) for the Treatment of Cutaneous T-Cell Lymphoma (Mycosis Fungoides)
Condition: Cutaneous T-Cell Lymphoma
Interventions: Drug: SGX301 (synthetic hypericin);   Drug: Placebo
2 Completed A Phase I Dose Escalation Study of Synthetic Hypericin in HIV-Infected Patients With Less Than 300 CD4 Lymphocytes
Condition: HIV Infections
Intervention: Drug: Hypericin
3 Completed A Pharmacologically Guided Phase I/II Study of Daily Orally Administered Synthetic Hypericin in HIV-Infected Subjects
Condition: HIV Infections
Intervention: Drug: Hypericin

Indicates status has not been verified in more than two years